ArticleBlood2015

Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.